chikungunya
viru
chikv
aetiolog
agent
mosquitoborn
diseas
chikungunya
fever
debilit
arthrit
diseas
past
year
caus
immeasur
morbid
mortal
human
includ
newborn
babi
follow
emerg
dispers
africa
indian
ocean
island
asia
sinc
first
report
exist
africa
scientif
public
differ
aspect
diseas
caus
agent
produc
analysi
public
show
follow
number
studi
absenc
autochthon
case
develop
countri
interest
scientif
commun
remain
low
howev
chikungunya
fever
unexpectedli
reemerg
form
devast
epidem
around
indian
ocean
outbreak
associ
mutat
viral
genom
facilit
replic
viru
aed
albopictu
mosquito
sinc
nearli
public
chikungunya
fever
referenc
pubm
databas
articl
provid
comprehens
review
chikungunya
fever
chikv
includ
clinic
data
epidemiolog
report
therapeut
aspect
data
relat
anim
model
vivo
laboratori
studi
includ
supplementari
tabl
outbreak
bulletin
prome
mail
alert
viral
sequenc
avail
genbank
pubm
report
clinic
case
seropreval
studi
chikungunya
viru
chikv
arthropodborn
viru
transmit
aed
ae
mosquito
first
isol
makond
plateau
southern
provinc
tanzania
former
tanganyika
viru
transmiss
cycl
requir
infect
femal
mosquito
via
viraem
bloodmeal
taken
suscept
vertebr
host
follow
suitabl
extrins
incub
period
transmiss
anoth
vertebr
host
subsequ
feed
solignat
et
al
incub
period
patient
suffer
polyarthralgia
myalgia
signific
impact
qualiti
life
chikungunya
fever
characteris
high
viraem
load
concomit
abnorm
pronounc
lymphopenia
moder
thrombocytopenia
rate
asymptomat
case
lower
percentag
infect
patient
requir
medic
attent
higher
common
arbovir
infect
acut
stage
patient
experienc
relaps
persist
arthralgia
musculoskelet
pain
increas
age
obviou
risk
factor
associ
sever
diseas
persist
symptom
adult
whilst
paediatr
popul
newborn
higher
risk
sever
diseas
sinc
first
report
chikungunya
fever
africa
earli
scientif
public
differ
aspect
diseas
caus
agent
produc
analysi
public
show
follow
number
studi
absenc
autochthon
case
develop
countri
interest
scientif
commun
remain
low
fig
howev
chikungunya
fever
unexpectedli
reemerg
form
devast
epidem
around
indian
ocean
outbreak
associ
mutat
viral
genom
facilit
replic
viru
aed
albopictu
mosquito
sinc
nearli
public
chikungunya
fever
referenc
pubm
databas
reader
refer
supplementari
tabl
list
outbreak
bulletin
prome
mail
alert
viral
sequenc
avail
genbank
pubm
report
clinic
case
seropreval
studi
two
distinct
transmiss
cycl
describ
chikv
sylvat
cycl
africa
urban
humanmosquitohuman
viru
transmiss
cycl
seen
asia
indian
ocean
africa
recent
europ
two
major
vector
diseas
current
identifi
ae
aegypti
sinc
ae
albopictu
import
role
ae
albopictu
recent
outbreak
due
adapt
mutat
viral
genom
particular
mutat
glycoprotein
increas
viral
replic
specif
vector
base
partial
structur
glycoprotein
complet
genom
sequenc
three
phylogroup
chikv
westafrican
asian
eastcentralsouthafrican
appar
circul
region
display
differ
ecolog
background
identifi
licenc
vaccin
chikungunya
commerci
avail
sever
strategi
studi
section
review
sever
drug
shown
antivir
activ
chikv
activ
inflammatori
symptom
associ
chikv
infect
treatment
standard
present
chikungunya
fever
current
reli
paracetamolacetaminophen
nonsteroid
antiinflammatori
drug
chloroquin
recommend
acut
phase
diseas
ribavirin
use
sever
present
limit
inform
avail
confirm
efficaci
recent
investig
may
lead
identif
new
antivir
candid
clearli
defin
mechan
viral
inhibit
cellbas
system
signific
activ
anim
model
therapeut
protocol
sever
case
may
also
establish
base
specif
immunoglobulin
molecul
interfer
aspect
inflammatori
respons
associ
chikv
infect
chronic
rheumat
manifest
inflammatori
polyarthr
last
month
diseasemodifi
antirheumat
drug
methotrex
recommend
describ
studi
anim
model
suggest
inflamm
macrophag
tissu
tropism
local
viral
persist
involv
establish
chronic
diseas
chikv
belong
alphaviru
genu
famili
togavirida
enserink
king
et
al
power
logu
chikv
first
isol
serum
febril
patient
outbreak
occur
southern
provinc
tanzania
tanganyika
makond
plateau
robinson
ross
name
chikungunya
bantu
languag
makond
peopl
refer
stoop
postur
due
frequent
debilit
joint
pain
induc
chikungunya
fever
enserink
substanti
evid
chikv
transmit
dispers
mosquito
vector
particular
aed
speci
spp
gilotra
bhattacharya
gilotra
shah
mcintosh
et
al
paterson
mcintosh
sarkar
shah
et
al
weinbren
et
al
chikv
member
viru
semliki
forest
eurasia
viru
antigen
complex
togeth
number
alphavirus
found
africa
onyongnyong
viru
onnv
south
america
eg
mayaro
viru
australiaoceania
region
ross
river
viru
rrv
caus
acut
arthropathi
human
power
et
al
vanlandingham
et
al
virion
icosahedr
capsid
enclos
lipid
envelop
diamet
nm
sensit
desicc
temperatur
genom
singlestrand
posit
sens
rna
molecul
approxim
kb
length
khan
et
al
fig
genom
organis
arrang
other
alphavirus
two
open
read
frame
orf
end
genom
cap
polyadenyl
signal
end
orf
translat
genom
rna
encod
four
nonstructur
protein
jose
et
al
orf
translat
subgenom
rna
encod
polyprotein
process
capsid
protein
c
two
surfac
envelop
glycoprotein
two
small
peptid
design
king
et
al
simizu
et
al
voss
et
al
glycoprotein
embed
heterodimer
form
viral
envelop
respons
viru
attach
membran
fusion
viru
fusion
cell
membran
mediat
glycoprotein
class
ii
fusion
protein
process
depend
lowph
acid
condit
induc
conform
chang
viru
envelop
protein
dissoci
heterodim
format
homotrim
trimer
insert
target
membran
via
hydrophob
fusion
peptid
refold
form
hairpinlik
structur
cholesterol
requir
cell
membran
fusion
bud
alphaviru
infect
solignat
et
al
larg
number
recent
studi
dedic
structur
characteris
envelop
protein
alphavirus
fig
organis
chikv
genom
gene
product
genom
organis
arrang
alphavirus
two
open
read
frame
orf
cap
structur
poli
tail
proxim
sequenc
chikv
genom
includ
nontransl
region
ntr
junction
region
j
also
noncod
orf
translat
genom
rna
encod
four
nonstructur
protein
orf
translat
subgenom
rna
encod
capsid
protein
c
two
surfac
envelop
glycoprotein
two
small
peptid
design
differ
nonstructur
protein
structur
protein
c
capsid
envelop
gener
proteolyt
cleavag
polyprotein
precursor
adapt
solignat
et
al
author
permiss
structur
modif
occur
fusion
gibbon
et
al
li
et
al
liu
kielian
roussel
et
al
voss
et
al
zhang
et
al
chikv
replic
cycl
essenti
similar
replic
cycl
alphavirus
solignat
et
al
nonstructur
protein
cleavag
intermedi
involv
rna
replic
five
structur
protein
c
cleavag
intermedi
requir
viral
encapsid
bud
fro
et
al
leung
et
al
replic
occur
cytoplasm
vertebr
insect
cell
close
associ
golgi
apparatu
viru
enter
cell
plasma
membran
mostli
endocytosi
via
phdepend
mechan
culmin
fusion
pore
format
releas
nucleocapsid
cytosol
fig
begin
attach
primarili
respons
interact
cellular
receptor
fusion
viru
particl
membran
host
cell
fusion
peptid
locat
tip
molecul
domain
ii
close
amino
acid
howev
chikv
resist
mutant
select
adapt
growth
presenc
high
concentr
arbidol
molecul
typic
block
fusion
boriskin
et
al
leneva
et
al
includ
singl
amino
acid
substitut
localis
envelop
protein
suggest
close
cooper
protein
necessari
fusion
process
incub
period
chikungunya
fever
never
investig
great
detail
rang
day
often
cite
burt
et
al
singh
unni
outbreak
occur
amongst
group
highschool
children
pretoria
visit
northern
transvaal
bushveld
two
day
arriv
first
camper
taken
ill
overal
incub
period
episod
estim
vari
day
fouri
morrison
amongst
case
import
metropolitan
franc
indian
ocean
outbreak
patient
defin
onset
diseas
departur
endem
area
mean
durat
incub
follow
arriv
repres
minim
durat
incub
day
ci
rang
day
median
day
data
institut
de
veill
sanitair
inv
person
commun
harold
data
global
accord
medic
literatur
support
belief
incub
period
gener
short
day
proport
individu
infect
chikv
develop
clinic
symptom
requir
medic
attent
higher
arbovir
infect
chastel
follow
fig
life
cycl
chikv
infect
cell
viru
enter
cell
plasma
membran
mostli
endocytosi
via
phdepend
mechan
culmin
fusion
pore
format
releas
nucleocapsid
cytosol
begin
attach
primarili
respons
interact
cellular
receptor
fusion
viru
particl
host
cell
membran
fusion
peptid
locat
tip
molecul
domain
ii
close
amino
acid
follow
viru
entri
two
round
translat
occur
positivesens
genom
rna
act
directli
mrna
partial
translat
end
produc
nonstructur
protein
nsp
protein
respons
replic
format
complementari
neg
strand
templat
positivestrand
synthesi
subgenom
mrna
replic
occur
synthesi
fulllength
neg
intermedi
rna
regul
precursor
earli
infect
later
matur
nsp
translat
subgenom
rna
result
product
structur
protein
c
requir
viral
encapsid
bud
assembl
occur
cell
surfac
envelop
acquir
viru
bud
cell
releas
matur
occur
almost
simultan
thiboutot
et
al
permiss
break
chikungunya
fever
sever
recent
seropreval
studi
perform
indic
differ
rate
asymptomat
case
rang
outbreak
reunion
island
case
report
symptom
includ
know
gerardin
et
al
sever
month
outbreak
itali
case
posit
serolog
declar
symptom
moro
et
al
similarli
outbreak
mayott
case
posit
serolog
declar
clinic
sign
could
compat
histori
chikungunya
fever
sissoko
et
al
two
year
chikungunya
fever
outbreak
state
kerala
india
seropreval
studi
found
amongst
patient
posit
serolog
declar
symptom
compat
histori
chikungunya
fever
kumar
et
al
studi
amongst
french
militari
policemen
chikungunya
outbreak
reunion
island
case
report
symptom
queyriaux
et
al
final
casecontrol
studi
thailand
laboratoryproven
chikv
infect
case
consid
asymptomat
viral
load
observ
symptomat
individu
significantli
differ
observ
virem
asymptomat
individu
appassakij
et
al
sinc
indian
ocean
outbreak
inform
avail
scientif
commun
relat
specif
clinic
characterist
patient
infect
chikv
significantli
increas
two
stage
diseas
describ
acut
ill
late
stage
ill
persist
arthropathi
sever
recent
prospect
studi
current
avail
describ
accur
acut
stage
ill
bandyopadhyay
ghosh
borgherini
et
al
chow
et
al
nkogh
et
al
queyriaux
et
al
rezza
et
al
riyaz
et
al
simon
et
al
staikowski
et
al
taubitz
et
al
thibervil
et
al
win
et
al
symptomat
patient
gener
report
abrupt
onset
diseas
characteris
high
fever
polyarthralgia
backach
headach
fatigu
fever
characterist
clinic
symptom
appear
within
day
polyarthralgia
report
case
repres
characterist
symptom
joint
pain
mostli
polyarticular
bilater
symmetr
occur
mainli
peripher
joint
wrist
ankl
phalang
larg
joint
shoulder
elbow
knee
joint
swell
less
frequent
case
pain
ligament
pubalgia
sternocleidomastoid
occipit
insert
talalgia
temporomandibular
sternocostoclavicular
joint
tenosynov
also
describ
myalgia
observ
case
recent
prospect
studi
whilst
retrospect
studi
report
higher
preval
myalgia
observ
predominantli
arm
thigh
calv
without
myositi
cutan
manifest
report
case
characteris
macular
maculopapular
rash
involv
mainli
extrem
trunk
face
skin
lesion
transient
mostli
occur
day
onset
diseas
generalis
pruritu
report
onefourth
case
larg
varieti
skin
mucou
membran
lesion
also
report
acut
stage
diseas
hypermelanosi
hyperpigment
photosensit
exfoli
dermat
vesicl
bulla
vasculit
lesion
erythema
nodosum
like
lesion
exacerb
preexist
dermatos
psoriasi
mucos
ulcer
digest
symptom
diarrhoea
vomit
nausea
abdomin
pain
occur
case
acut
stage
diseas
consequ
chikungunya
fever
major
impact
qualiti
life
acut
stage
ill
incapacit
limit
normal
activ
occur
case
whilst
tired
consid
signific
signific
case
psycholog
impact
observ
patient
depress
demoralis
recent
studi
describ
classic
daili
evolut
day
onset
main
symptom
cohort
outpati
infect
chikv
reunion
island
outbreak
two
stage
identifi
viral
stage
day
associ
rapid
decreas
viraemia
follow
rapid
improv
clinic
present
convalesc
stage
day
associ
detect
viraemia
slow
clinic
improv
thibervil
et
al
acut
stage
chikungunya
fever
characteris
high
viraem
load
pfuml
averag
median
durat
viraemia
day
rang
day
concomit
abnorm
pronounc
lymphopenia
andor
moder
thrombocytopenia
prospect
seri
case
reunion
island
outbreak
patient
lymphopenia
cellsmm
sever
cellsmm
case
lymphopenia
pronounc
patient
higher
viraemia
moder
thrombocytopenia
cellsmm
cellsmm
record
patient
less
common
biolog
abnorm
observ
leukopenia
elev
liver
enzym
anemia
elev
creatinin
elev
creatinin
kinas
hypocalcemia
differenti
chikungunya
fever
possibl
etiolog
import
physician
notabl
ensur
good
manag
outpati
retrospect
serolog
studi
mayott
island
outbreak
sissoko
et
al
found
fever
togeth
polyarthralgia
provid
sensit
se
posit
predict
valu
ppv
neg
predict
valu
npv
prospect
studi
patient
suspect
chikungunya
fever
recent
outbreak
gabon
fever
arthralgia
se
ppv
npv
respect
nkogh
et
al
anoth
studi
staikowski
et
al
report
chikv
posit
patient
increas
frequenc
skin
rash
arthralgia
feet
wrist
asthenia
higher
temperatur
lower
frequenc
digest
symptom
pruritu
chikv
neg
patient
retrospect
studi
aim
compar
dengu
chikungunya
fever
present
chikungunya
independ
associ
arthralgia
rash
whilst
dengu
associ
myalgia
rais
aspart
transaminas
leucopaenia
mohd
zim
et
al
biolog
paramet
also
associ
chikvposit
patient
notabl
lymphopenia
elev
liver
enzym
anemia
elev
creatinin
nkogh
et
al
staikowski
et
al
recent
clinic
clinicobiolog
diagnost
score
base
cohort
outpati
reunion
island
outbreak
propos
use
simpl
criteria
arthralgia
hand
wrist
minor
absent
myalgia
combin
clinicobiolog
score
clinic
score
presenc
lymphopenia
thibervil
et
al
acut
stage
describ
patient
experi
relaps
persist
symptom
clinic
descript
risk
factor
late
stage
recent
gain
increas
interest
evid
sever
studi
borgherini
et
al
bouquillard
comb
couturi
et
al
de
andrad
et
al
gerardin
et
al
hoarau
et
al
manimunda
et
al
marimout
et
al
moro
et
al
narsimulu
prabhu
nkogh
et
al
ribera
et
al
simon
et
al
sissoko
et
al
thibervil
et
al
win
et
al
amongst
symptom
declar
late
stage
arthralgia
musculoskelet
pain
frequent
longlast
sign
follow
chikungunya
fever
outbreak
reunion
island
sever
studi
prospect
followedup
patient
present
chronic
rheumat
manifest
rheumatoid
arthriti
ra
accord
american
colleg
rheumatolog
acr
criteria
spondylarthopathi
nonclassifi
rheumat
diagnos
associ
chikungunya
fever
other
symptom
less
frequent
report
fever
fatigu
headach
neuropath
pain
syndrom
cerebr
disord
sensorineur
impair
dysesthesia
andor
paraesthesia
carpal
tarsal
cubit
tunnel
syndrom
digest
disord
skin
involv
rash
alopecia
pruritu
bilater
raynaud
phenomenon
erythermalgia
joint
stiff
bursiti
tenosynov
synov
without
effus
consequ
qualiti
life
psycholog
health
could
impair
late
stage
except
patient
diagnosi
ra
standard
laboratori
find
includ
inflammatori
marker
remark
within
normal
limit
stage
proport
chikungunya
patient
fulli
recov
partial
improv
persist
symptom
vari
studi
accord
time
studi
assess
onset
diseas
case
frequenc
person
present
symptom
chikungunya
fever
decreas
increas
time
onset
crosssect
studi
outbreak
reunion
island
patient
declar
suffer
less
one
month
one
three
month
still
suffer
averag
day
onset
diseas
outpati
cohort
reunion
island
outbreak
approxim
patient
declar
incomplet
recoveri
persist
arthralgia
day
onset
diseas
twelv
month
outbreak
itali
case
still
report
least
one
frequent
symptom
arthralgia
myalgia
asthenia
arthralgia
respect
anoth
studi
month
outbreak
mayott
patient
report
perman
symptom
report
experienc
least
one
episod
recurr
contrast
outbreak
gabon
patient
recov
fulli
day
onset
diseas
west
india
epidem
suffer
musculoskelet
pain
arthriti
year
diseas
onset
respect
dupui
maguiraga
et
al
review
host
virolog
factor
record
late
stage
clinic
diseas
increas
age
associ
longer
durat
ill
presenc
joint
pain
late
stage
infect
contrast
age
risk
factor
chronic
diseas
outbreak
singapor
possibl
due
younger
popul
studi
preexist
joint
pain
osteoarthr
comorbid
also
associ
increas
risk
persist
symptom
femal
gender
associ
longer
durat
ill
persist
symptom
univari
analysi
amongst
biolog
marker
acut
stage
viral
load
associ
persist
symptom
reunion
island
outbreak
wherea
relationship
viral
load
late
stage
found
outbreak
singapor
strong
earli
immunoglobulin
respons
trigger
high
viral
load
also
propos
protect
chronic
longterm
effect
chikv
infect
recent
two
studi
observ
posit
associ
high
titr
chikv
specif
igg
antibodi
long
last
arthralgia
gerardin
et
al
moro
et
al
one
studi
peak
creatinin
level
significantli
lower
patient
persist
arthralgia
win
et
al
sinc
chikv
known
affect
central
nervou
system
recent
indian
ocean
outbreak
neurolog
complic
report
less
case
seizur
often
report
patient
past
medic
histori
epilepsi
andor
histori
heavi
alcohol
consumpt
neurolog
complic
report
encephalopathi
enceph
guillainbarr
encephalomyeloradicul
subarachnoid
cerebellar
haemorrhag
borgherini
et
al
da
et
al
staikowski
et
al
haemorrhag
sign
rare
patient
minor
bleed
nose
gum
borgherini
et
al
win
et
al
case
associ
clot
abnorm
major
thrombocytopenia
nkogh
et
al
staikowski
et
al
varieti
clinic
symptom
report
acut
stage
chikungunya
fever
conjunct
neuroretin
iridocycl
myocard
pericard
pneumonia
dri
cough
lymphadenopathi
nephriti
hepat
pancreat
borgherini
et
al
economopoul
et
al
mahendrada
et
al
mirabel
et
al
nair
et
al
rajapaks
et
al
renault
et
al
rezza
et
al
rose
et
al
simon
et
al
simon
et
al
staikowski
et
al
win
et
al
overal
atyp
case
estim
symptomat
case
reunion
island
outbreak
economopoul
et
al
amongst
atyp
case
consid
sever
admit
intens
care
unit
die
economopoul
et
al
report
caus
death
heart
failur
multipl
organ
failur
syndrom
toxic
hepat
enceph
bullou
dermatosi
respiratori
failur
renal
failur
pneumonia
acut
myocardi
infarct
cerebrovascular
diseas
hypothyroid
septicaemia
reunion
island
outbreak
excess
deathrat
observ
mortal
associ
chikungunya
fever
report
casefat
ratio
josseran
et
al
similar
casefat
ratio
observ
follow
outbreak
port
blair
capit
citi
union
territori
andaman
nicobar
island
india
manimunda
et
al
howev
comparison
expect
observ
mortal
reunion
island
identifi
highmort
rate
januari
may
lowmort
rate
rest
year
suggest
exist
harvest
phenomenon
impli
global
excess
death
might
overestim
deriv
epidem
period
children
clinic
manifest
chikungunya
fever
appear
quit
specif
although
rheumatolog
manifest
less
frequent
remain
group
high
risk
atyp
sever
manifest
main
clinic
characterist
infant
high
preval
dermatolog
manifest
hyperpigment
generalis
erythema
maculopapular
rash
vesiculobul
lesion
neurolog
complic
enceph
seizur
mening
syndrom
acut
encephalopathi
clinic
featur
also
describ
digest
disord
loos
stool
peripher
cyanosi
minor
haemorrhag
manifest
robin
et
al
sebastian
et
al
valamparampil
et
al
although
chikungunya
fever
appar
observ
teratogen
effect
pregnanc
fritel
et
al
vertic
transmiss
report
first
time
reunion
island
outbreak
observ
exclus
nearterm
deliveri
context
intrapartum
viremia
rate
caesarean
section
protect
effect
transmiss
sever
ill
observ
newborn
mainli
consist
encephalopathi
persist
disabl
gerardin
et
al
other
complic
includ
seizur
haemorrhag
syndrom
haemodynam
disord
cardiolog
complic
myocardi
hypertrophi
ventricular
dysfunct
pericard
coronari
arteri
dilat
necrot
enterocol
dermatolog
manifest
nair
ram
et
al
rao
et
al
risk
factor
sever
acut
diseas
thoroughli
investig
borgherini
et
al
chow
et
al
economopoul
et
al
gerardin
et
al
gerardin
et
al
kam
et
al
kee
et
al
kumar
et
al
lohachanakul
et
al
ng
et
al
nkogh
et
al
paquet
et
al
renault
et
al
sissoko
et
al
staikowski
et
al
sever
studi
report
adult
incid
atyp
case
sever
case
hospitalis
mortal
rate
increas
age
pediatr
popul
newborn
high
risk
sever
diseas
although
comorbid
increas
age
often
link
comorbid
underli
respiratori
diseas
use
nsaid
prior
hospitalis
hypertens
underli
cardiac
disord
associ
hospitalis
diseas
sever
alcohol
abus
also
associ
increas
mortal
femal
gender
clearli
associ
sever
ill
indian
ocean
outbreak
women
overrepres
base
report
case
wherea
crosssect
studi
found
similar
seropreval
valu
gender
suggest
variabl
symptomat
diseas
depend
gender
contrast
singl
studi
male
blood
rhesusposit
individu
found
suscept
infect
chikv
case
report
immunocompromis
patient
describ
atyp
sever
diseas
studi
compar
immunocompromis
immunodeffici
patient
associ
viral
load
acut
sever
ill
controversi
inde
sever
studi
report
higher
viral
load
hospitalis
patient
patient
sever
ill
whilst
other
studi
reveal
signific
associ
viral
load
clinic
present
biolog
abnorm
immunolog
marker
propos
associ
diseas
sever
elev
liver
enzym
creatinin
c
reactiv
protein
crp
hypocalcemia
elev
decreas
rant
earli
chikvspecif
studi
precis
evalu
efficaci
variou
symptomat
treatment
usual
employ
acut
chronic
stage
chikungunya
fever
nevertheless
previous
publish
review
paracetamolacetaminophen
nonsteroid
antiinflammatori
drug
nsaid
recommend
aspirin
avoid
risk
bleed
system
corticosteroid
also
avoid
strong
rebound
effect
treatment
stop
ali
ou
alla
comb
burt
et
al
simon
et
al
singh
unni
sever
chronic
arthriti
diseasemodifi
antirheumat
drug
dmard
includ
methotrex
hydroxychloroquin
sulphasalazin
propos
bouquillard
comb
although
antitumour
necrosi
factora
antitnf
associ
exacerb
diseas
mous
model
earli
stage
ill
zaid
et
al
patient
diagnosi
postchikungunya
rheumatoid
arthriti
success
treat
antitnf
antibodi
bouquillard
comb
ribera
et
al
recent
propos
therapeut
protocol
patient
chronic
rheumat
manifest
patient
without
diagnosi
polyarthr
symptomat
treatment
analges
ladder
paracetamol
nsaid
codein
tramadol
kinesitherapia
muscl
relax
drug
acupunctur
phytotherapia
patient
defin
inflammatori
polyarthr
month
dmard
methotrex
propos
patient
respond
well
usual
analges
chronic
stage
neuropath
syndrom
care
evalu
assess
whether
specif
treatment
antiepilept
antidepress
could
use
allevi
suffer
de
andrad
et
al
main
chikv
mosquito
vector
ae
aegypti
stegomya
aegypti
ae
albopictu
stegomya
albopicta
recent
ae
aegypti
consid
primari
vector
chikv
transmiss
ae
albopictu
surprisingli
identifi
second
major
vector
viru
place
ae
aegypti
consid
rare
eg
reunion
island
also
place
mosquito
speci
prevel
eg
madagascar
india
gabon
emerg
ae
albopictu
major
vector
chikv
larg
attribut
singl
mutat
protein
chikv
facilit
enhanc
viru
uptak
replic
transmiss
vector
tsetsarkin
et
al
ae
albopictu
recent
shown
remark
capac
adapt
peridomest
environ
enabl
displac
ae
aegypti
place
becom
signific
vector
chikv
denv
knudsen
africa
wide
rang
mosquito
also
incrimin
transmiss
chikv
ae
spp
ae
furcif
ae
taylori
ae
vittatu
ae
fulgen
ae
luteocephalu
ae
dalzi
ae
vigilax
ae
camptorhyntit
ae
africanu
also
culex
annulirostri
mansonia
uniformi
lam
et
al
yadav
et
al
human
be
serv
reservoir
host
viru
epidem
period
wherea
interepidem
period
sever
reservoir
host
incrimin
monkey
rodent
bird
inou
et
al
wolf
et
al
signific
nonhuman
primat
reservoir
host
discuss
section
devot
pathogenesi
two
distinct
transmiss
cycl
describ
chikv
sylvat
cycl
africa
wolf
et
al
gener
pattern
resembl
yellow
fever
viru
sylvat
cycl
ie
involv
viru
transmiss
forestor
savannahassoci
mosquito
nonhuman
primat
possibl
rodent
occasion
spillov
viru
nearbi
human
popul
live
close
sylvat
environ
latter
circumst
viru
may
encount
mosquito
primarili
associ
urban
environ
ie
domest
peridomest
mosquito
thu
initi
urban
humanmosquitohuman
viru
transmiss
cycl
seen
asia
indian
ocean
africa
recent
europ
gener
ae
aegypti
predomin
vector
urban
outbreak
epidem
resembl
viru
transmiss
cycl
dengu
viru
urban
environ
africa
chikv
maintain
sylvat
cycl
involv
wild
nonhuman
primat
varieti
forestdwel
mosquito
speci
power
logu
ae
africanu
uganda
bangui
ae
cordellieri
south
africa
ae
furcifertaylori
south
africa
seneg
ae
luteocephalu
ae
dalzi
seneg
jupp
mcintosh
mcintosh
et
al
rural
region
africa
outbreak
tend
affect
small
popul
appear
heavili
depend
sylvat
mosquito
popul
densiti
increas
period
heavi
rainfal
thonnon
et
al
howev
recent
outbreak
cameroon
congo
gabon
chikv
vector
asian
mosquito
ae
albopictu
gradual
widen
geograph
rang
asia
africa
europ
america
benedict
et
al
current
principl
factor
inde
respons
mainten
ae
albopictusadapt
viru
life
cycl
sylvat
environ
defin
asia
chikv
maintain
humanmosquitohuman
urban
cycl
involv
ae
aegypti
ae
albopictu
whether
transmiss
cycl
exclus
mosquito
speci
yet
known
yet
fulli
investig
mani
year
chikv
persist
thought
depend
primarili
upon
continu
introduct
viru
immunolog
popul
power
logu
howev
evid
long
last
persist
asian
genotyp
see
infra
sever
recent
studi
suggest
sylvat
cycl
could
also
play
part
transmiss
chikv
asia
power
et
al
apandi
et
al
chikv
endem
epidem
africa
asia
sinc
indian
ocean
kariuki
njenga
et
al
power
logu
case
chikungunya
fever
retriev
literatur
differ
public
health
alert
system
shown
fig
b
follow
paragraph
summaris
inform
relat
viru
circul
origin
endem
area
ie
africa
asia
recent
epidemiolog
expans
possibl
introduct
viru
nonendem
area
infect
travel
fig
supplementari
tabl
list
outbreak
bulletin
prome
mail
alert
viral
sequenc
avail
genbank
pubm
report
clinic
case
seropreval
studi
first
human
document
epidem
caus
chikv
recognis
east
africa
austral
africa
tanzania
uganda
zimbabw
mason
haddow
weinbren
weinbren
et
al
asia
first
epidem
document
bangkok
aikat
et
al
volk
et
al
follow
number
outbreak
document
philippin
cambodia
vietnam
lao
myanmar
malaysia
indonesia
halstead
et
al
b
viru
implic
caus
epidem
philippin
thailand
myanmar
khai
ming
et
al
singapor
sri
lanka
hermon
mendi
vesenjakhirjan
et
al
cambodia
chastel
india
malaysia
vietnam
vu
qui
nguyenthi
taiwan
indonesia
porter
et
al
pakistan
darwish
et
al
ancient
possibl
case
chikungunya
fever
asia
report
carey
ng
hapuarachchi
includ
widespread
epidem
selflimit
febril
ill
africa
caribbean
west
indi
india
larg
proport
popul
calcutta
current
kolkatta
india
affect
subsequ
case
calcutta
possibl
origin
zanzibar
spread
aden
red
sea
calcutta
burma
myanmar
java
note
whilst
epidem
pattern
would
locat
ancient
report
case
chikungunya
fever
asia
fulli
compat
african
origin
outbreak
south
africa
mcintosh
et
al
paterson
mcintosh
power
logu
angola
pinto
filip
niger
nigeria
moor
et
al
power
logu
tomori
et
al
central
african
republ
pastorino
et
al
saluzzo
et
al
democrat
republ
congo
pastorino
et
al
ivori
coast
malawi
sudan
watt
et
al
seneg
power
logu
roch
robin
thonnon
et
al
zimbabw
power
logu
uganda
power
logu
kenya
kariuki
njenga
et
al
power
logu
democrat
republ
congo
declar
epidem
muyembetamfum
et
al
period
epidem
identifi
sequenti
kenya
seneg
sudan
cameroon
gabon
epidem
report
first
time
republ
congo
kelvin
paradox
knowledg
natur
histori
environment
cycl
viru
africa
remain
fragmentari
whilst
infect
nonhuman
primat
may
act
reservoir
amplifi
host
demonstr
see
section
pathogenesi
viru
identifi
varieti
sylvat
mosquito
see
previou
section
determin
emerg
remain
poorli
understood
africa
asia
outbreak
report
unpredict
interv
year
individu
epidem
power
logu
interv
decad
major
epidem
whilst
precis
factor
underli
pattern
unknown
probabl
addit
varieti
ecolog
viral
genet
factor
given
long
last
immun
protect
acquir
chikungunya
infect
immun
statu
popul
play
central
role
period
recurr
coher
observ
recurr
outbreak
prefenti
target
youngest
agegroup
ie
non
immunis
previou
epidem
robert
et
al
mauritiu
promedmail
access
number
outbreak
guangdong
provinc
china
chikungunya
fever
report
wu
et
al
interestingli
detail
clinic
report
david
bylon
citi
batavia
current
jakarta
indonesia
year
highli
evoc
chikungunya
see
ng
hapuarachchi
may
long
time
mistakenli
report
document
dengu
fever
carey
halstead
understand
origin
asian
genotyp
chikv
remain
fragmentari
probabl
first
document
case
report
bangkok
reflect
ancient
circul
chikv
region
thu
explain
extent
genet
diverg
eastcentralsouthafrican
ecsa
asian
genotyp
accord
ng
et
al
ng
hapuarachchi
avail
histor
clinic
record
suggest
chikungunya
fever
outbreak
asia
sinc
suggest
independ
evolut
african
ancestor
chikv
asia
sever
centuri
result
asian
genotyp
howev
difficult
accommod
recent
estim
chikv
evolutionari
rate
sinc
recent
ancestor
asian
ecsa
genotyp
place
begin
centuri
cherian
et
al
volk
et
al
altern
report
chikungunya
fever
jakarta
exact
may
implic
limit
import
chikv
africa
instal
asian
genotyp
occur
later
possibl
end
centuri
global
chikungunya
epidemiolog
situat
asia
remain
poorli
document
first
respect
role
endem
asian
genotyp
genotyp
includ
virus
respons
indian
ocean
outbreak
poorli
investig
despit
evid
cocircul
area
eg
india
indonesia
see
fig
note
ng
hapuarachchi
whilst
ecsa
genotyp
take
centr
stage
recent
asian
outbreak
asian
lineag
fade
oblivion
recent
case
report
malaysia
kumarasami
et
al
singapor
ng
hapuarachchi
taiwan
huang
et
al
see
also
fig
longstand
persist
asian
genotyp
recent
isol
asian
genotyp
strain
wild
macaqu
monkey
malaysia
apandi
et
al
evoc
sylvat
mainten
remain
document
power
et
al
secondli
seroepidemiolog
studi
requir
understand
depth
level
exposur
popul
thu
propos
cartographi
risk
may
outbreak
chikungunya
fever
affect
popul
kenyan
coast
first
identifi
lamu
island
epidem
peak
reach
juli
subsequ
appear
comoro
island
decemb
schuffeneck
et
al
epidem
peak
record
end
march
mostli
affect
grand
comor
ngazidja
island
epidem
encompass
inhabit
island
entir
southwest
indian
ocean
mayott
reunion
island
mauritiu
seychel
madagascar
fig
importantli
outbreak
start
spread
area
preval
vector
ae
aegypti
ie
kenya
comoro
seychel
area
madagascar
transmiss
mosquito
extrem
effici
sinc
crosssect
seropreval
studi
perform
week
epidem
peak
repres
sampl
lamu
island
kenya
popul
reveal
popul
present
antichikungunya
antibodi
sergon
et
al
similarli
crosssect
seropreval
studi
perform
repres
sampl
grand
comor
island
march
report
seropreval
consider
social
impact
one
half
infect
individu
take
work
leav
sergon
et
al
littl
inform
avail
regard
situat
mauritiu
preval
vector
ae
albopictu
first
detect
epidem
wave
occur
marchjun
second
peak
march
lara
et
al
case
report
sinc
august
absenc
seropreval
data
number
case
offici
declar
less
popul
presum
consider
underestim
seychel
archipelago
first
suspect
case
report
juli
first
limit
case
peak
septemb
second
peak
occur
februari
probabl
reflect
limit
impact
first
wave
third
peak
occur
mayjun
total
attack
rate
estim
popul
sinc
end
decemb
suspect
case
occasion
notifi
retrospect
seropreval
studi
conduct
madagascar
epidemiolog
data
scarc
initi
case
mostli
establish
travel
return
island
clinic
epidemiolog
studi
made
difficult
cocircul
dengu
period
impact
chikungunya
outbreak
probabl
import
chikungunya
fever
suspect
endem
present
island
sinc
sever
case
import
madagascar
identifi
reunion
island
probabl
outbreak
affect
southeast
madagascar
consid
end
march
seropreval
data
avail
reunion
mayott
island
french
oversea
territori
chikungunya
outbreak
analys
detail
pialoux
et
al
renault
et
al
reunion
island
ae
albopictu
epidemiolog
relev
vector
first
peak
outbreak
observ
may
case
incid
decreas
becam
stabl
around
case
per
week
austral
winter
second
peak
reach
januaryfebruari
case
singl
week
popul
less
inhabit
last
indigen
case
report
decemb
retrospect
seroepidemiolog
studi
show
approxim
popul
infect
demonstr
massiv
impact
epidem
caus
dispers
viru
gerardin
et
al
agreement
prospect
surveil
data
report
symptomat
infect
attack
rate
sever
present
requir
assist
least
one
vital
function
die
sever
present
patient
year
age
detect
die
forti
four
case
mothertoinf
transmiss
report
economopoul
et
al
new
indigen
cluster
observ
west
island
case
dortenzio
et
al
second
cluster
detect
region
march
saintpaul
case
first
case
detect
march
epidemiolog
investig
establish
probabl
unnotic
viru
circul
island
unlik
probabl
origin
outbreak
import
case
madagascar
associ
high
vector
densiti
outbreak
hous
index
breteau
index
collect
around
chikungunya
fever
case
much
higher
level
epidem
risk
defin
suffici
prevent
autochthon
transmiss
chikungunya
fever
reunion
island
mayott
case
detect
februaryjun
second
peak
observ
attack
rate
estim
case
notifi
sinc
april
sri
lanka
maldiv
outbreak
appear
novemb
decemb
respect
yoosuf
et
al
follow
explos
epidem
involv
million
peopl
least
indian
state
kalantri
et
al
lahariya
pradhan
viru
appar
virtual
absent
previou
year
wide
report
citi
india
experienc
massiv
outbreak
chikungunya
fever
earli
recent
epidem
spread
pakistan
malaysia
singapor
thailand
pulmanausahakul
et
al
chikungunya
fever
europ
america
import
case
import
case
report
franc
grandadam
et
al
krastinova
et
al
germani
frank
et
al
switzerland
bodenmann
genton
norway
base
public
health
report
countri
unit
kingdom
belgium
spain
czech
republ
see
supplementari
tabl
surprisingli
import
case
report
western
europ
attempt
creat
risk
stratifi
surveil
zone
europ
indic
franc
itali
like
greater
risk
due
number
visitor
receiv
chikungunya
activ
region
princip
virem
visitor
india
tilston
et
al
import
case
also
report
north
america
canada
french
guyana
brazil
guadeloup
martiniqu
new
caledonia
australia
bonilauri
et
al
depoorter
et
al
parola
et
al
despit
abund
ae
mosquito
area
evid
signific
autochthon
transmiss
chikv
may
part
due
activ
surveil
import
case
may
also
indic
spread
viru
popul
hamper
undetermin
entomolog
ecolog
reason
nevertheless
recent
studi
suggest
vectori
compet
local
ae
albopictu
effici
typic
vector
ae
aegypti
chikv
denv
vegarua
et
al
mmwr
outbreak
autochthon
chikungunya
fever
case
occur
itali
outbreak
initi
individu
return
europ
visit
india
viru
respons
outbreak
dissemin
emilia
romagna
region
northern
itali
ae
albopictu
mosquito
recent
septemb
autochthon
transmiss
chikv
record
southeastern
franc
two
confirm
case
gould
et
al
grandadam
et
al
conclus
epidemiolog
impact
recent
chikungunya
fever
outbreak
prove
consider
region
epidem
spread
high
seroconvers
rate
observ
commonli
around
enorm
social
econom
burden
inflict
affect
commun
de
andrad
et
al
enserink
krishnamoorthi
et
al
queyriaux
et
al
moreov
despit
limit
proport
case
outbreak
signific
impact
health
servic
due
high
proport
symptomat
case
sinc
chikungunya
fever
associ
extrem
high
earli
viremia
risk
bloodborn
transmiss
viru
high
likelihood
interrupt
blood
suppli
transfus
report
affect
countri
minimis
risk
transmiss
via
infect
blood
product
brouard
et
al
liumbruno
et
al
ng
et
al
although
direct
persontoperson
transmiss
report
nosocomi
transmiss
probabl
occur
follow
needlestick
injuri
ie
skin
accident
punctur
use
contamin
needl
howev
context
outbreak
nosocomi
natur
transmiss
difficult
establish
interestingli
publish
case
document
nosocomi
infect
report
franc
cold
epidemiolog
context
associ
import
case
reunion
island
highlight
risk
transmiss
health
care
worker
parola
et
al
chikv
outbreak
reunion
island
cornea
taken
asymptomat
donor
prove
infect
chikv
transmiss
viru
occur
via
ocular
rout
couderc
et
al
first
focus
phylogenet
analysi
chikv
identifi
three
phylogroup
base
partial
viral
structur
glycoprotein
sequenc
chikv
strain
repres
differ
geograph
lineag
appar
circul
region
display
differ
ecolog
background
three
genotyp
westafrican
asian
eastcentralsouthafrican
ecsa
power
et
al
schuffeneck
et
al
geograph
distribut
differ
genotyp
describ
elsewher
volk
et
al
summaris
fig
gener
believ
geograph
origin
viru
africa
support
sever
observ
ng
hapuarachchi
genet
diverg
group
virus
westafrican
genotyp
ecsa
asian
genotyp
paraphylet
phylogenet
reconstruct
cherian
et
al
power
et
al
volk
et
al
complex
sylvat
cycl
known
report
longer
period
time
africa
region
larger
number
vertebr
host
invertebr
vector
identifi
africa
ie
propiti
condit
creat
observ
viral
genet
divers
ancestr
diverg
time
estim
westafrican
ecsa
genotyp
compar
asian
genotyp
cherian
et
al
volk
et
al
basi
recent
indepth
phylogenet
analys
avail
chikv
isol
fig
evolutionari
timescal
chikv
estim
past
year
cherian
et
al
volk
et
al
support
scenario
sylvat
african
chikv
emerg
human
pathogen
probabl
centuri
wherea
current
identifi
epidem
genotyp
westafrican
asian
ecsa
estim
emerg
centuri
import
recent
event
spread
ecsa
lineag
indian
ocean
asia
strain
form
monophylet
group
within
ecsa
lineag
one
branch
includ
mostli
indian
strain
strain
subsequ
export
variou
asian
european
american
countri
strain
identifi
south
west
indian
ocean
island
strain
subsequ
export
progenitor
virus
implic
schuffeneck
et
al
strong
epidemiolog
experiment
evid
adapt
mutat
increas
viral
replic
ae
albopictu
tsetsarkin
et
al
mutat
report
occur
independ
differ
geograph
locat
differ
genet
background
within
ecsa
genotyp
see
case
gabones
strain
repres
exel
exampl
converg
evolut
amino
acid
posit
differ
strain
chikv
howev
must
note
origin
nonmut
ae
aegyptiadapt
strain
extrem
effici
transmit
region
mosquito
preval
seropreval
reach
grand
comor
lamu
ismand
see
previou
section
accordingli
propos
emerg
epidem
viru
link
initi
adapt
urban
domest
ae
aegypti
mosquito
ng
hapuarachchi
postul
support
compel
evid
urban
transmiss
ecsa
genotyp
chikv
central
africa
past
decad
page
et
al
adapt
mutat
ae
albopictu
increas
transmiss
mosquito
tsetsarkin
et
al
tsetsarkin
et
al
margin
compromis
viral
fit
ae
aegypti
tsetsarkin
et
al
vazeil
et
al
despit
appar
high
frequenc
adapt
evolut
occur
chikv
genet
background
limit
strain
belong
ecsa
genotyp
complex
pattern
mutat
may
implic
chikv
adapt
specif
ae
spp
vector
tsetsarkin
et
al
tsetsarkin
et
al
particular
substitut
suspect
provid
background
render
possibl
mutat
report
occur
independ
three
occas
south
africa
gabon
kenya
howev
whilst
mutat
present
asian
genotyp
mutat
never
observ
genotyp
experiment
mutagenesi
fail
creat
effici
ae
albopictusadapt
asian
genotyp
virus
includ
mutat
tsetsarkin
et
al
demonstr
lineagespecif
epistat
interact
substitut
amino
acid
posit
envelop
glycoprotein
restrict
abil
endem
asian
chikv
strain
adapt
ae
albopictu
author
identifi
addit
substitut
caus
signific
increas
abil
chikv
develop
dissemin
infect
ae
albopictu
effect
chikv
fit
ae
aegypti
vertebr
cell
line
sever
recent
public
studi
cell
suscept
chikv
replic
panel
immortalis
primari
human
cell
analys
demonstr
human
epitheli
endotheli
cell
primari
fibroblast
lesser
extent
monocytederiv
macrophag
suscept
chikv
infect
wherea
replic
identifi
lymphoid
monocytoid
cell
line
primari
lymphocyt
monocyt
monocytederiv
dendrit
cell
sourisseau
et
al
chikv
also
isol
tremend
varieti
continu
diploid
cell
line
includ
mammalian
cell
vero
bgm
hela
etc
amphibian
cell
xtc
mosquito
cell
ae
etc
anim
model
chikv
detect
cytoplasm
numer
mononuclear
cell
spleen
lymph
node
moreov
sinusoid
endothelium
liver
macrophag
identifi
main
cellular
reservoir
late
stage
chikv
infect
macaqu
model
labadi
et
al
mous
model
fibroblast
constitut
main
target
cell
chikv
joint
muscl
dermal
tissu
whilst
skelet
muscl
cell
chikv
rare
present
satellit
cell
infect
leukocyt
detect
blood
central
nervou
system
choroid
plexu
epitheli
cell
ependymocyt
infect
contrast
microgli
cell
astrocyt
microvascular
endotheli
cell
chikv
found
placent
tissu
addit
human
syncytiotrophoblast
cell
line
bewo
found
refractori
infect
couderc
et
al
human
viral
growth
muscl
satellit
cell
detect
wherea
myotub
essenti
refractori
infect
ozden
et
al
biopsi
skelet
muscl
joint
skin
chikv
antigen
also
detect
appear
confin
fibroblast
joint
capsul
skelet
muscl
fascia
dermi
couderc
et
al
chikv
also
found
hoarau
et
al
perivascular
synovi
macrophag
one
chronic
patient
month
post
infect
pi
histor
mous
model
choic
follow
suscept
arboviru
infect
thu
often
use
studi
viru
cycl
diseas
model
particularli
clear
sindbi
viru
sinv
induc
arthriti
human
larg
use
model
studi
virusinduc
enceph
mice
highlight
main
difficulti
associ
use
mous
model
assess
accur
mimic
diseas
human
term
specif
sever
recent
review
dedic
purpos
numer
studi
limit
major
adult
wildtyp
wt
mous
strain
asymptomat
follow
standard
viru
inocul
intraperiton
intraderm
intraven
subcutan
sc
thu
mainli
neonat
mice
interferon
ifn
ab
receptor
knockout
mice
use
model
deriv
ifna
pathway
defect
mice
rudd
et
al
provid
inform
innat
immun
respons
alphavirus
use
drug
test
sinc
mortal
rate
organ
viral
load
use
conveni
indic
antivir
activ
use
variou
mutant
ifna
pathway
defect
mice
enabl
mechan
innat
immun
respons
specif
chikv
deciph
couderc
et
al
gardner
et
al
schilt
et
al
schilt
et
al
wernek
et
al
implic
role
viperin
teng
et
al
recent
rel
role
autophagi
pathway
host
respons
chikv
also
assess
use
mice
joubert
et
al
recent
suhrbier
collabor
provid
model
chikungunya
rheumat
diseas
mice
shift
site
inject
dorsal
side
footpad
gardner
et
al
subcutan
sc
inject
rout
provid
histolog
evid
acut
persist
arthriti
tenosynov
myositi
infect
footpad
similar
observ
rrv
infect
mice
rulli
et
al
acut
phase
characteris
oneweek
viral
replic
peak
clear
swell
oedema
inocul
foot
gardner
et
al
morrison
et
al
tissu
viral
replic
detect
day
muscl
spleen
lymph
node
liver
addit
adult
mous
model
shown
mice
initi
infect
rrv
partial
protect
superinfect
chikv
strain
inocul
week
later
mice
young
age
remain
factor
sever
diseas
also
observ
human
babi
mechan
neurolog
diseas
perfectli
compat
observ
follow
intranas
infect
balbc
mice
direct
tissu
necrosi
observ
olfactori
lobe
direct
infect
neuron
found
final
recent
studi
use
mice
demonstr
inadequ
ifnab
respons
follow
viru
infect
suffici
induc
haemorrhag
fever
shock
find
possibl
implic
understand
sever
chikv
diseas
rudd
et
al
altogeth
current
mous
model
abl
depict
longlast
chronic
arthralg
featur
found
chikvinfect
patient
schilt
et
al
submit
even
gene
profil
chikv
arthriti
mous
model
reveal
signific
overlap
rheumatoid
arthriti
nakaya
et
al
howev
mous
model
conveni
remain
specif
interest
vivo
screen
drug
target
acut
phase
infect
nhp
use
extens
studi
virusinduc
patholog
evalu
drug
vaccin
number
diseas
vierboom
et
al
walsh
et
al
earli
histori
chikv
studi
found
nhp
suscept
infect
probabl
part
natur
reservoir
africa
asia
inou
et
al
marchett
et
al
mccrae
et
al
peiri
et
al
field
epidemiolog
studi
central
africa
central
african
republ
gabon
cercopithecu
baboon
monkey
use
sentinel
assess
presenc
arbovirus
wild
saluzzo
et
al
saluzzo
et
al
saluzzo
et
al
african
green
monkey
macaqu
also
use
sentinel
estim
vector
efficaci
differ
mosquito
speci
jupp
et
al
levitt
et
al
turel
beaman
turel
malinoski
studi
led
identif
major
relev
ae
spp
epidem
outbreak
first
experiment
chikv
infect
achiev
rhesu
macaca
mulata
bonnet
macaqu
radiata
mulata
show
episod
fever
within
day
viru
inocul
binn
et
al
paul
singh
viral
replic
pattern
macaqu
similar
report
human
asian
strain
plasma
viremia
found
posit
macaqu
day
viral
titr
rang
pfuml
binn
et
al
paul
singh
earli
experi
littl
record
concern
clinic
sign
associ
infect
perhap
due
technic
limit
amazingli
paul
sing
studi
note
rate
infect
ae
albopictu
consist
higher
ae
aegypti
speci
mosquito
fed
simultan
virem
macaqu
despit
premonitori
observ
ae
albopictu
regard
minor
potenti
vector
chikv
indian
ocean
outbreak
spread
india
southeast
asia
subsequ
wild
macaqu
suscept
infect
report
follow
epidemiolog
studi
inou
et
al
peiri
et
al
earli
studi
chikv
infect
nhp
focus
macaqu
mosquito
transmiss
efficaci
turel
beaman
turel
malinoski
recent
roqu
collabor
infect
cynomolgu
macaqu
macaca
fasciculari
use
reunion
island
strain
chikv
follow
biomark
chikv
found
replic
detect
first
week
infect
level
replic
similar
human
infect
labadi
et
al
perform
vivo
titrat
demonstr
littl
pfu
given
iv
could
produc
infect
macaqu
virem
level
pfuml
detect
day
postinfect
pi
chikv
detect
cerebrospin
fluid
test
macaqu
clinic
neurolog
diseas
detect
macaqu
receiv
highest
infecti
dose
interestingli
acut
infect
seem
tightli
control
poorlycharacteris
antivir
mechan
given
viral
titr
reduc
basal
level
day
postinfect
describ
human
mice
ziegler
et
al
viral
replic
profil
also
record
rhesu
macaqu
akahata
et
al
chen
et
al
human
earli
leukopenia
observ
akahata
et
al
borgherini
et
al
borgherini
et
al
labadi
et
al
togeth
marker
antivir
respons
ifnab
inflamm
cell
immun
activ
higg
ziegler
labadi
et
al
whilst
viru
found
cerebrospin
fluid
sampl
acut
phase
infect
viral
presenc
central
nervou
system
clearli
relat
neuron
diseas
like
associ
nonspecif
inflamm
rare
case
might
associ
encephalopathi
anim
infect
larg
amount
viru
probabl
case
neonat
patient
gerardin
gerardin
et
al
labadi
et
al
recent
studi
cynomolgu
macaqu
demonstr
chikv
persist
target
tissu
clearanc
blood
demonstr
viral
rna
detect
use
situ
hybrid
assay
labadi
et
al
day
chikv
detect
nearli
everi
organ
compart
test
joint
secondari
lymphoid
organ
lesser
extent
muscl
affect
viru
genet
materi
well
isol
replic
chikv
obtain
month
pi
chikv
replic
sever
cell
type
acut
phase
higg
ziegler
labadi
et
al
thereaft
mainli
detect
macrophag
immunohistochem
analysi
doubl
stain
infect
monocyt
macrophag
could
detect
blood
h
infect
roqu
et
al
tissu
follow
day
situ
hybrid
immunohistochemistri
rtpcr
viru
isol
signific
macrophag
infiltr
also
detect
histolog
analysi
throughout
studi
long
viral
clearanc
blood
labadi
et
al
monocytemacrophag
tropism
consist
infect
human
monocyt
vitro
infect
monocyt
gener
new
virus
detect
use
cell
titrat
assay
albeit
low
level
et
al
similarli
chikv
infect
primari
macrophag
vitro
rinaldo
et
al
sourisseau
et
al
result
product
highli
variabl
amount
viru
pfuml
regardless
speci
use
studi
human
macaqu
mous
gardner
et
al
labadi
et
al
sourisseau
et
al
fig
result
consist
human
studi
report
macrophag
suscept
chikv
infect
vivo
vitro
hoarau
et
al
krejbichtrotot
et
al
allevi
chikungunyaassoci
arthriti
myositi
treatment
bindarit
inhibitor
mice
also
strongli
suggest
monocytesmacrophag
main
target
tissu
tropism
central
muscl
joint
diseas
see
treatment
section
current
anim
model
fulli
reproduc
chronic
rheumatoid
syndrom
chikungunya
fever
inde
diseas
pictur
mice
mainli
driven
destruct
tissu
huge
cell
infiltr
gardner
et
al
morrison
et
al
rulli
et
al
despit
viru
persist
sever
joint
damag
observ
macaqu
labadi
fig
accumul
chikv
protein
macaqu
monocytederiv
macrophag
day
postinfect
labadi
et
al
monocytederiv
macrophag
separ
monocyt
adhes
day
infect
moi
chikv
express
protein
macrophag
grow
glass
slide
fix
conterstain
dapi
pictur
acquir
use
confoc
spe
leica
microscop
et
al
nevertheless
model
suggest
inflamm
macrophag
tissu
tropism
local
viral
persist
involv
establish
chronic
diseas
vaccin
chikungunya
current
avail
first
attempt
develop
inactiv
vaccin
report
end
involv
deterg
treatment
viru
white
et
al
unfortun
formalinkil
vaccin
show
promis
appear
moder
immunogen
limit
short
time
effect
clinic
trial
harrison
et
al
live
attenu
vaccin
often
effect
particularli
arbovirus
live
vaccin
better
induc
rapid
protect
homolog
heterolog
challeng
us
armi
develop
live
attenu
vaccin
base
asian
strain
serial
passag
cell
result
viru
chik
carri
signific
genet
chang
hoke
et
al
levitt
et
al
show
promis
protect
nhp
challeng
later
test
clinic
trial
show
good
immunogen
edelman
et
al
mcclain
et
al
howev
sever
advers
event
associ
sever
arthralgia
vaccine
loss
inform
vaccin
product
nolong
consid
suitabl
clinic
use
use
proof
concept
studi
evalu
potenti
mechan
protect
resist
viru
induc
diseas
thu
probe
attenu
protect
efficaci
attenu
vaccin
strain
mice
compromis
ifn
signal
show
infect
mice
defect
ifnab
ifnc
receptor
signal
chik
viru
result
rapid
mortal
within
day
contrast
infect
mice
defect
ifnab
receptor
signal
surviv
temporari
morbid
characteris
ruffl
appear
bodi
weight
loss
heterozygot
mice
retain
partial
ifnab
receptor
signal
activ
remain
healthi
infect
mice
chik
viru
induc
signific
level
ifnc
whilst
inflammatori
cytokin
ifna
remain
low
singl
administr
chik
vaccin
strain
provid
shortterm
longterm
protect
day
day
postprim
respect
challeng
wt
chikvla
reunion
chikvlr
protect
least
partial
mediat
antibodi
sinc
passiv
transfer
immun
serum
protect
mice
wt
chikvlr
chik
viru
challeng
data
accord
other
studi
show
ifnab
defici
greatli
exacerb
arthritogen
diseas
mice
infect
wt
chikv
couderc
et
al
gardner
et
al
cell
cultureadapt
liveattenu
chik
vaccin
candid
gorchakov
et
al
weaver
group
show
attenu
chik
vaccin
strain
determin
two
amino
acid
substitut
envelop
glycoprotein
test
two
differ
murin
strain
infant
day
adult
mice
defect
ifn
pathway
gorchakov
et
al
overal
data
highlight
import
ifn
control
chik
vaccin
strain
demonstr
abil
vaccin
elicit
neutralis
antibodi
respons
confer
shortand
longterm
protect
wt
chikvlr
challeng
vaccin
base
recombin
envelop
protein
indian
strain
chikv
adjuv
alum
fca
montanid
elicit
balanc
respons
virusneutralis
antibodi
balbc
mice
author
challeng
mice
khan
et
al
kumar
et
al
evalu
recombin
proteinbas
wholeviru
inactiv
candid
vaccin
given
intramuscularli
chikv
balbc
mice
test
adjuv
alum
mw
cadb
alummw
formalininactiv
chikv
alum
bplinactiv
chikv
humor
immun
assess
elisa
vitro
neutralis
test
use
homolog
heterolog
asian
genotyp
strain
chikv
two
cohort
vaccin
mice
challeng
separ
via
intranas
rout
homolog
viru
week
second
dose
antichikvantibodi
titr
dose
depend
immunogen
formul
bplinactiv
vaccin
led
highest
elisaneutralis
antibodi
nab
titr
whilst
alum
effect
adjuv
adult
balbc
mouseintranas
infect
model
week
complet
protect
observ
follow
immunis
alumadjuv
inactiv
vaccin
viru
detect
tissu
muscl
brain
spleen
blood
real
time
pcr
challeng
week
weekspostth
second
vaccin
dose
howev
low
viremia
record
second
daypostchalleng
global
major
vaccin
trial
mice
even
simpl
inactiv
system
whole
chikv
particl
inactiv
aziridin
brown
gave
effect
protect
low
lg
vaccin
adult
mice
week
age
suppress
viremia
leg
oedema
vlp
repres
chikv
envelop
protein
produc
renal
epitheli
cell
human
kidney
cell
line
infect
lentiviru
vector
contain
subgenom
rna
sequenc
akahata
et
al
author
show
use
vlp
plu
ribi
adjuv
antibodi
respons
time
higher
use
dna
vaccin
sequenc
balbc
mice
could
detect
final
report
protect
mice
ifnar
nonhuman
primat
challeng
strain
chikv
howev
amount
produc
vlp
remain
low
system
mgl
within
supernat
medium
method
improv
recent
author
show
specif
domain
chikv
protein
aminoacid
regul
particl
format
human
cell
akahata
nabel
thu
product
function
vlp
might
enhanc
fold
group
wageningen
univers
develop
product
vlp
use
chimer
baculoviru
salmonid
alphaviru
sav
insect
cell
obtain
function
process
secret
recent
develop
process
obtain
chikv
vlp
within
chimer
baculoviru
first
vaccin
assay
viru
challeng
experi
perform
use
suhrbier
mous
model
system
pijlman
chimer
alphavirus
develop
contain
venezuelan
equin
enceph
viru
veev
equin
enceph
viru
eev
nonstructur
protein
code
sequenc
chikv
structur
protein
code
sequenc
program
attenu
celltyperestrict
phenotyp
lack
old
world
alphaviru
new
world
alphaviru
capsid
involv
innat
cell
respons
shutdown
make
virus
incap
transmiss
mosquito
vector
differenti
regul
express
viral
structur
protein
replic
made
depend
intern
ribosom
entri
site
ire
deriv
encephalomyocard
viru
ire
plant
et
al
design
genom
complement
select
procedur
adapt
virus
replic
tissu
cultur
produc
variant
demonstr
differ
level
replic
product
individu
structur
protein
ii
effici
induc
antivir
respons
infect
cell
iii
could
replic
mosquito
cell
darwin
et
al
iv
effici
replic
vero
cell
final
vaccin
candid
test
highli
sensit
mice
ifnab
found
deleteri
contrast
chik
vaccin
strain
effici
induc
protect
immun
respons
wang
et
al
abl
provid
crossprotect
alphavirus
semliki
forest
antigen
complex
use
procedur
chikv
vaccin
candid
partido
et
al
induc
crossprotect
immun
adult
mice
ifnab
ifnc
onnv
week
post
vaccin
author
also
show
transplacent
passiv
antichikv
antibodi
transfer
week
old
offspr
vaccin
dam
protect
onnv
intraderm
challeng
use
complet
differ
strategi
genphar
develop
recombin
adenoviru
cadvaxchikv
contain
codon
optimis
sequenc
contain
chikv
structur
gene
vaccin
test
use
suhrbier
mous
model
wang
et
al
week
postvaccin
reciproc
neutralis
titr
rnt
close
similar
titr
observ
infect
wild
type
chikv
protect
cytopath
effect
ccid
viru
mice
challeng
day
vaccin
shown
fulli
protect
foot
swell
viral
replic
undetect
compar
ccid
control
group
recombin
virus
test
mice
includ
chimer
vesiculoalphaviru
entir
chikv
envelop
polyprotein
express
chattopadhyay
et
al
vsvgchikv
chimera
attenu
tissu
cultur
propag
high
titr
without
vsvg
complement
shown
protect
adult
mice
challeng
day
postvaccin
sc
rout
inocul
left
rear
footpad
morrison
model
effici
vaccin
assess
neutralis
antibodi
use
plaqu
reduct
neutralis
test
ifnc
elispot
assay
peptid
cell
howev
studi
viral
replic
diseas
induc
chikv
nonvaccin
mice
high
pfuml
day
ie
order
magnitud
valu
obtain
two
other
studi
gardner
et
al
teng
et
al
perhap
shorter
delay
vaccin
challeng
plasmid
contain
codon
rnastructureoptimis
protein
sequenc
without
peptid
includ
furin
cleavag
site
well
kozakig
leader
sequenc
end
genom
gener
geneart
regensburg
germani
vaccin
perform
subsequ
electropor
quadricep
femal
balbc
mice
mallilankaraman
et
al
one
week
third
electropor
chikv
neutralis
antibodi
significantli
enhanc
rnt
median
produc
protect
cytopath
effect
use
challeng
dose
viru
high
chikv
specif
cellular
respons
demonstr
measur
ifnc
elispot
assay
peptid
pool
cell
construct
thu
induc
improv
immun
respons
compar
previou
contruct
group
muthumani
et
al
time
mice
challeng
intranas
exposur
pfu
strain
ecsa
genotyp
summari
mice
protect
high
morbid
normal
associ
intranas
infect
ie
spongiform
lesion
apoptot
bodi
microgli
nodul
extern
granular
layer
cerebr
cortex
sever
myocardi
liver
degenerationnecrosi
requir
euthanasia
control
mice
day
pi
despit
mark
weight
loss
first
day
vaccin
mice
return
normal
valu
thereaft
howev
vaccin
anim
sacrifi
day
pi
microgli
oedema
seen
brain
suggest
immunis
decreas
chikvmedi
patholog
fulli
protect
brain
intranas
inocul
model
contrast
diseas
mice
vaccin
dna
express
chikv
capsid
induc
morbid
pictur
ident
control
nonimmunis
mice
final
mallilankaraman
et
al
test
immun
respons
induc
follow
vaccin
strategi
four
rhesu
macaqu
immun
two
week
later
detect
variabl
neutralis
antibodi
respons
rnt
specif
cell
respons
pbmc
challeng
anim
thu
candid
vaccin
except
one
far
test
mice
studi
mainli
focus
neutralis
antibodi
cellular
respons
literatur
unclear
whether
vaccin
proceed
human
clinic
trial
addit
recent
studi
shown
recognis
protect
immun
respons
chikv
consist
predominantli
antibodi
earli
neutralis
igg
respons
chikv
infect
patient
target
domin
linear
epitop
glycoprotein
kam
et
al
kam
et
al
howev
anoth
studi
report
chikv
abl
escap
impact
neutralis
antibodi
direct
celltocel
transmiss
observ
impli
effect
vaccin
assess
pure
abil
induc
detect
neutralis
antibodi
conclus
whilst
evid
effect
vaccin
chikv
infect
clearli
need
inactiv
vaccin
unlik
provid
strong
longlast
immun
almost
inevit
requir
multipl
dose
thu
reduc
cost
effect
dna
vaccin
thu
far
prove
less
effect
human
mammal
live
attenu
alphavirus
use
genet
backbon
vaccin
develop
chiron
alphavax
other
approach
like
lead
effect
vaccin
longlast
immun
chikv
howev
remain
determin
whether
inevit
high
develop
cost
safe
effect
live
attenu
chimaer
vaccin
chikv
prove
restrain
influenc
novel
method
attenu
virus
burn
et
al
coleman
et
al
mueller
et
al
mueller
et
al
song
et
al
recent
appli
chikv
strain
ecsa
genotyp
nucleic
acid
composit
larg
code
region
modifi
without
modifi
encod
protein
introduc
larg
number
synonym
mutat
nougaired
et
al
use
revers
genet
method
synonym
mutat
randomli
introduc
three
region
around
kb
encod
structur
nonstructur
protein
synonym
mutat
introduc
repres
complet
genom
viru
replic
fit
result
reencod
virus
studi
cellulo
use
primat
mosquito
cell
introduc
larg
number
presum
slightli
deleteri
synonym
mutat
significantli
decreas
replic
fit
chikv
primat
arthropod
cell
diminut
correl
directli
degre
reencod
give
possibl
modul
precis
degre
fit
loss
use
sever
reencod
region
locat
throughout
viral
genom
reduc
likelihood
complet
phenotyp
revers
due
recombin
wildtyp
reencod
chikv
addit
stabil
reencod
virus
assess
serial
passag
virus
time
either
primat
insect
cell
cell
line
altern
analysi
passag
virus
show
exhibit
stabl
phenotyp
respons
codon
reencod
larg
compensatori
natur
littl
revers
mutat
studi
anim
model
obvious
need
evalu
potenti
reencod
chikv
produc
vaccin
candid
import
messag
gener
attenu
strain
chikv
largescal
reencod
repres
potenti
import
rout
vaccin
develop
method
modifi
amino
acid
sequenc
therefor
potenti
allevi
likelihood
novel
phenotyp
properti
also
provid
advantag
live
attenu
vaccin
includ
reduc
cost
singl
dose
induct
longterm
immun
sever
drug
known
effect
chikv
test
vitro
recognis
antivir
treatment
current
avail
passiv
immunotherapi
use
centuri
treatment
viral
infecti
diseas
recent
studi
monkey
immunis
vaccin
base
chikv
vlp
immunoglobulin
g
igg
extract
sera
monkey
administ
passiv
mice
infect
chikv
immun
igg
protect
mice
infect
chikv
akahata
et
al
human
immunoglobulin
purifi
plasma
chikv
convalesc
patient
also
exhibit
high
vitro
neutralis
activ
power
prophylact
therapeut
efficaci
chikv
infect
mice
recent
human
recombin
monoclon
antibodi
exhibit
strong
specif
neutralis
activ
vitro
test
wide
varieti
chikv
strain
abl
significantli
delay
chikvdriven
lethal
mice
ifna
bc
fric
et
al
warter
et
al
passiv
immunotherapi
may
constitut
efficaci
prevent
strategi
treatment
individu
expos
chikv
risk
sever
infect
neonat
born
virem
mother
adult
chronic
underli
medic
condit
ifn
system
capabl
inhibit
viru
infect
absenc
adapt
immun
treatment
cell
ifnab
upregul
express
sever
hundr
gene
combin
specifi
antivir
state
singl
gene
pivot
given
viru
subset
gene
probabl
requir
limit
viral
replic
sever
upregul
gene
encod
enzym
studi
intens
dsrnadepend
protein
kinas
r
pkr
oligoadenyl
synthetas
oa
mxa
randal
goodbourn
import
current
applic
ifn
therapi
antivir
treatment
chronic
phase
viral
infect
hcv
hbv
heim
nevertheless
ifn
therapi
also
propos
acut
viral
infect
sar
influenza
wang
fish
ifn
known
inhibit
growth
virus
within
genu
alphaviru
lukaszewski
brook
pinto
et
al
case
sinv
found
balanc
type
ifn
induct
abil
viru
develop
round
infect
determin
first
hour
viru
replic
low
number
cell
infecti
viru
involv
frolov
et
al
anoth
studi
emerg
alphaviru
salmonid
aquacultur
call
salmonid
sensit
preinfect
antivir
state
induc
ifna
whilst
pi
antivir
respons
pi
treatment
ifna
abl
limit
viral
replic
xu
et
al
consist
recent
studi
mice
found
ifna
treatment
prevent
arthriti
due
chikv
given
infect
sinc
situat
would
exist
case
human
infect
ifna
like
prove
use
therapi
gardner
et
al
smallmolecul
drug
ribavirin
ribavirin
nucleosid
analogu
exhibit
antivir
activ
varieti
rna
virus
cell
cultur
least
three
distinct
mechan
inhibit
cellular
protein
inosin
monophosph
dehydrogenas
impdh
immunomodulatori
effect
incorpor
mutagen
nucleosid
viral
rna
polymeras
three
activ
may
play
antivir
role
vivo
crotti
et
al
ribavirin
known
inhibit
cellulo
larg
rang
rna
virus
notabl
virus
genu
alphaviru
semliki
forest
viru
sfv
chikv
ho
et
al
smee
et
al
anim
model
ribavirin
effect
limit
set
virus
mainli
rna
virus
human
ribavirin
current
use
combin
interferona
treat
hepat
c
viru
hcv
infect
use
monotherapi
lassa
fever
sever
respiratori
syncyti
viru
rsv
infect
crotti
et
al
vivo
antivir
activ
ribavirin
chikungunya
fever
report
recent
nonrandomis
human
cohort
statist
analysi
avail
due
small
number
particip
ravichandran
manian
combin
interferon
ribavirin
found
exert
synergist
antivir
effect
two
alphavirus
chikv
sfv
vitro
briolant
et
al
chloroquin
chloroquin
hydroxyanalogu
hydroxychloroquin
weak
base
known
affect
acid
vesicl
lead
dysfunct
sever
enzym
virus
enter
target
cell
endocytosi
lysosom
compart
low
ph
along
action
enzym
disrupt
viral
particl
thu
liber
infecti
nucleic
acid
sever
case
enzym
necessari
viral
replic
envelop
virus
posttransl
modif
envelop
glycoprotein
also
occur
within
endoplasm
transgolgi
network
vesicl
involv
proteas
glycosyltransferas
requir
low
ph
thu
shown
chloroquin
hydroxychloroquin
impair
replic
sever
virus
interact
endosomemedi
viral
entri
late
stage
replic
envelop
virus
savarino
et
al
potenti
cellulo
applic
chloroquin
antivir
treatment
first
report
year
ago
inglot
case
alphavirus
notabl
sfv
also
report
chloroquin
enhanc
viru
replic
mice
maheshwari
et
al
vitro
inhibit
chikv
replic
chloroquin
report
distinguish
antiinflammatori
effect
previous
report
patient
chronic
stage
infect
brighton
doubleblind
placebocontrol
randomis
trial
evalu
efficaci
chloroquin
chikungunya
fever
identifi
signific
differ
chloroquin
placebo
group
term
either
mean
durat
febril
arthralgia
decreas
viremia
day
moreov
day
postinfect
patient
treat
chloroquin
declar
frequent
still
suffer
arthralgia
patient
receiv
placebo
conclus
whilst
vitro
inhibit
chikv
replic
strongli
establish
narrow
therapeut
index
absenc
obviou
biolog
clinic
improv
clinic
trial
argu
favour
cur
use
chloroquin
noncompl
case
chikungunya
fever
suggest
previou
similar
favour
result
obtain
cellulo
chloroquin
highli
pathogen
virus
sarscov
keyaert
et
al
consid
care
arbidol
antivir
drug
arbidol
arb
monohydr
develop
centr
drug
chemistri
moscow
use
respiratori
viral
infect
arb
report
clinic
activ
influenza
b
virus
respiratori
syncyti
viru
rsv
respiratori
virus
recent
hcv
brook
et
al
addit
possibl
immunemodulatori
effect
antivir
activ
arb
could
part
due
membranotrop
recent
data
show
arb
incorpor
cellular
membran
lead
perturb
membran
structur
inhibit
viru
mediat
fusion
inde
shown
arb
entri
inhibitor
influenza
viru
infect
stabil
influenza
ha
prevent
endosom
membran
fusion
similarli
arb
inhibit
hcv
glycoprotein
conform
chang
need
membran
fusion
process
recent
studi
found
arb
also
effect
chikv
vitro
conclud
arb
interfer
earli
stage
chikv
infect
viru
attach
entri
target
cellular
membran
alphaviru
envelop
glycoprotein
initi
produc
first
precursor
virion
matur
cleav
short
multibas
motif
amongst
cellular
proteas
basic
amino
acidspecif
furin
furinlik
proprotein
convertas
pc
shown
involv
calciumdepend
process
result
cleavag
surfac
glycoprotein
ozden
et
al
sinc
demonstr
uncleav
glycoprotein
precursor
induc
defect
viral
product
alphavirus
sinv
sfv
recent
studi
test
hypothesi
irrevers
furininhibit
peptid
decanoylrvkrchloromethyl
keton
decrvkrcmk
could
inhibit
chikv
infect
ozden
et
al
like
alphavirus
envelop
glycoprotein
chikv
initi
produc
precursor
cleav
furinlik
proprotein
convertas
pc
voss
et
al
decrvkrcmk
induc
cellulo
stronger
inhibit
viral
infect
chloroquin
ad
immedi
follow
infect
combin
drug
induc
addit
effect
enhanc
drug
ad
cell
viru
ozden
et
al
structurebasedspecif
inhibitor
crystal
structur
replic
protein
chikv
sever
alphavirus
report
lampio
et
al
malet
et
al
russo
et
al
voss
et
al
provid
new
opportun
develop
structurebas
specif
inhibitor
use
principl
singh
et
al
identifi
four
lead
compound
larg
librari
compound
potenti
could
inhibit
proteas
chikv
base
homolog
model
crystal
structur
protein
veev
recent
lucashourani
et
al
identifi
amongst
molecul
one
natur
compound
inhibit
chikv
replic
vitro
interf
activ
inhibitor
viru
replic
seri
complex
polycycl
molecul
isol
rare
nativ
plant
new
caledonia
trigonostemon
cherrieri
trigocherrin
trigocherriolid
recent
test
cellular
assay
chikv
sinv
sfv
comparison
select
indic
led
conclus
current
trigocherrin
potent
identifi
inhibitor
chikv
replic
mechan
inhibit
yet
determin
allard
et
al
allard
et
al
recent
anoth
speci
genu
trigonostemon
howii
collect
central
vietnam
also
prove
potent
inhibitor
chikv
similarli
product
extract
leav
madagascan
plant
anacolosa
pervilleana
demonstr
moder
activ
vitro
chikv
replic
bourjot
et
al
bourjot
et
al
recent
kaur
et
al
identifi
amongst
highli
purifi
natur
product
compound
librari
cephalotaxin
alkaloid
call
harringtonin
display
potent
inhibit
chikv
infect
affect
chikv
rna
product
well
viral
protein
express
minim
cytotox
peptideconjug
phosphorodiamid
morpholino
oligom
ppmo
nucleas
resist
watersolubl
singlestrandeddnaanalogu
enter
cell
readili
act
stericblock
antisens
agent
stabl
duplex
format
complementari
rna
stein
appli
cellulo
ppmo
decreas
viral
titr
sever
order
magnitud
reduc
viral
replic
andor
increas
surviv
mice
experiment
infect
polioviru
coxsackieviru
dengu
viru
west
nile
viru
respiratori
syncyti
viru
ebola
viru
influenza
viru
alphaviru
veev
paessler
et
al
stein
small
interf
rna
sirna
ancient
highli
conserv
natur
mechan
induc
doublestrand
rna
defend
cellular
genom
infect
virus
transposon
sirna
specif
degrad
rna
cytoplasm
eukaryot
cell
hannon
success
utilis
inhibit
replic
mani
rna
dna
virus
influenza
human
immunodefici
viru
japanes
enceph
viru
west
nile
viru
foot
mouth
diseas
viru
hepat
b
viru
herp
simplex
viru
notabl
alphavirus
veev
sfv
dash
et
al
dash
et
al
design
two
sirna
bind
conserv
region
chikv
genom
ad
cell
h
postinfect
sirna
produc
signific
viral
inhibit
reduc
infecti
viru
titr
total
viral
load
anoth
studi
sirna
use
inhibit
autophagi
machineri
chikvinfect
cell
sirna
transcript
beclin
autophag
protein
procedur
substanti
decreas
chikv
replic
krejbichtrotot
et
al
recent
plasmidbas
small
hairpin
rna
shrna
chikv
gene
provid
signific
inhibit
infecti
viru
product
vitro
strong
sustain
antichikv
protect
also
confer
suckl
mice
pretreat
shrna
lam
et
al
sphingosin
kinas
activ
recent
review
carr
et
al
summaris
inform
avail
regard
sphingosin
kinas
activ
viru
infect
carr
et
al
propos
potenti
therapeut
agent
treatment
cancer
immunolog
inflammatori
disord
catalys
phosphoryl
form
sphingosin
gener
axi
well
describ
role
cell
signal
viz
cell
deathsurviv
decis
product
proinflammatori
respons
immunomodul
control
vascular
integr
author
argu
clinic
pictur
chikungunya
fever
similar
pain
joint
syndrom
rheumatoid
arthriti
ra
accordingli
could
play
signific
role
infect
rna
virus
inde
data
suggest
rais
systemat
reduc
activ
local
joint
appear
benefici
effect
clinic
case
ra
moreov
lyas
inhibitor
investig
ra
mechan
arthritogen
alphavirus
chikv
caus
diseas
poorli
understood
inflammatori
respons
infect
contribut
viral
elimin
blood
clinic
recoveri
acut
stage
chronic
form
diseas
dupuismaguiraga
et
al
also
suggest
macrophag
play
critic
role
inflammatori
respons
dupuismaguiraga
et
al
inhibitor
monocyt
chemotact
protein
mcp
synthesi
call
bindarit
recent
shown
potent
antiinflammatori
drug
caus
system
immunosuppress
affect
arachidon
acid
metabol
rulli
et
al
clinic
trial
confirm
posit
safeti
bindarit
oral
avail
rulli
et
al
two
recent
studi
bindarit
treatment
improv
articular
symptom
chikv
rrv
diseas
mice
reduc
tissu
destruct
without
affect
viral
load
tissu
rulli
et
al
rulli
et
al
summari
antivir
drug
current
avail
treatment
standard
present
chikungunya
fever
chloroquin
use
past
utilis
acut
phase
diseas
base
data
collect
prospect
clinic
trial
reunion
island
sever
present
ribavirin
may
propos
limit
inform
avail
precis
indic
treatment
therapeut
protocol
eg
dose
durat
establish
howev
posit
note
current
investig
may
lead
identif
new
antivir
candid
increas
number
molecul
associ
clearli
defin
mechan
viral
inhibit
cellbas
system
show
signific
activ
anim
model
therapeut
protocol
sever
case
chikungunya
fever
may
also
establish
base
specif
immunoglobulin
molecul
interfer
aspect
inflammatori
respons
associ
chikv
infect
